US government sues Gilead for patent infringement over HIV drugs

The US government is suing Gilead for patent infringement, claiming that the pharmaceutical company has been piggybacking on public research to earn billions from its HIV drugs.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

Gilead suffers defeat at PTAB in government PrEP battle

6 February 2020 Gilead has suffered a blow in its efforts to invalidate the US government’s patent rights for PrEP, as the Patent Trial and Appeal Board threw out two of its four patent challenges.

Americas

US govt PrEP patents are invalid, Gilead tells court

27 January 2020 Gilead Sciences has accused a US government agency of withholding information from the US Patent and Trademark Office when filing two patents for HIV pre-exposure prophylaxis.

Americas

Sanders calls on USPTO to block Gilead patent extension

9 December 2019 US presidential candidate Bernie Sanders has called on the US Patent and Trademark Office to block extensions to two Gilead Sciences patents covering HIV prevention drugs including Descovy.

More features

Killing the golden goose of US drug innovation (Part II): Drug pricing myths

Former pharma GC brings in-house perspective to McGuireWoods

Sandoz eyes US biosimilar launch as Regeneron settles

Killing the golden goose of US drug innovation (Part I): Follow the money

Buchalter brings in new partner to head up medtech

Trump’s march-in rights threat: Why pharma is rethinking collaborations

UK gets new IP minister following cabinet reshuffle

Barnes & Thornburg reveals five new IP leaders

US government sues Gilead for patent infringement over HIV drugs

More on this story

Editor's picks

Editor's picks

More features